Albemarle is trading 4.37% up at $140.06 after no clearly identifiable company-specific announcement emerged for August 21, 2026.

  • The most recent major catalyst was the August 5 second-quarter report, which showed $1.74 billion in revenue and adjusted EBITDA of $858 million.
  • That report is stale and does not directly explain the move.
  • Broader pre-market sentiment is positive, though insufficient to establish causation.